Safety, Tolerability, and Immunogenicity of Revaccination With mRNA-1345 RSV Vaccine Administered 24 Months Following a Primary Dose in Adults ≥60 Years of Age

Journal of Infectious Diseases · Published 2026-07-07 · DOI 10.1093/infdis/jiag350

Free full text

Authors (7)

Mihir Desai, Gilberto Jimenez, Priyantha Wijewardane, Lan Lan, Lauren Wilson, Shraddha Mehta, Frances Priddy

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Desai, M., Jimenez, G., Wijewardane, P., et al. (2026). Safety, Tolerability, and Immunogenicity of Revaccination With mRNA-1345 RSV Vaccine Administered 24 Months Following a Primary Dose in Adults ≥60 Years of Age. Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiag350

Related articles